Compounding pharmacies in Virginia

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

The Virginia Board of Pharmacy (Virginia Department of Health Professions) regulates compounding pharmacies in Virginia. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Virginia at a glance

Pharmacy regulator: Virginia Board of Pharmacy (Virginia Department of Health Professions)
503A framework: Adds state-specific limits to the 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async allowed
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Virginia

No verified compounding pharmacies serving Virginia are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Virginia

The Virginia Board of Pharmacy regulates pharmacies under the Drug Control Act (Virginia Code title 54.1, chapter 34) and regulations at 18VAC110-20; regulation 18VAC110-20-321 requires compounding to follow USP-NF compounding standards and section 54.1-3410.2. That statute allows compounding for specific patient prescriptions or in anticipation of prescriptions based on an observed prescribing pattern, and subsection F sets Virginia's own two-part test for bulk drug substances: the substance must meet an applicable USP or NF monograph (if one exists) and the USP compounding chapter, or be a component of an FDA approved drug, or be otherwise approved by FDA, or be made by an FDA-registered establishment; and it must come from a licensed or registered wholesale distributor or a supplier approved by the Board and FDA. Neither section 54.1-3410.2 nor 18VAC110-20-321 mentions the FDA 503A bulks list, so the state test does not turn on that list; federal 503A limits, including the bulks list, still apply to every Virginia compounder, and the state sourcing and USP requirements add to them. Section 54.1-3434.1 requires nonresident pharmacies to register, designate a pharmacist in charge licensed in Virginia, and submit a home-state inspection (within six months for a new registration, two years for renewal) showing USP compliance for compounding. [1] [3] [4] [6] [7] [8]

Compounded GLP-1 access in Virginia

Out-of-state telehealth programs must dispense through a pharmacy registered under section 54.1-3434.1 with a Virginia-licensed pharmacist in charge. [3] [4] [11]

Research use only sellers in Virginia

The Virginia Drug Control Act restricts the sale and dispensing of Schedule VI (prescription-only) drugs to licensed practitioners and permitted or registered pharmacies, so injectable peptides sold to Virginia consumers as "research use only" are outside the licensed supply chain. [1] [5] [12]

Virginia notes on specific peptides

Semaglutide: A Schedule VI drug in Virginia, available branded by prescription, including after a real-time or store-and-forward telemedicine examination under section 54.1-3303. Compounded semaglutide is limited to the federal patient specific exception since the 503A grace period ended April 22, 2025. [2] [11]
BPC-157: Not FDA approved and not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk; a state board cannot authorize what federal law does not. Virginia's own bulk substance criteria in section 54.1-3410.2 add a second hurdle. [3] [9] [10]

How to check a compounding pharmacy in Virginia

Search the Virginia Board of Pharmacy (Virginia Department of Health Professions) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Virginia requires before it ships to you. [1] [3] [4] [6] [7] [8]
Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Virginia. [1] [5] [12]

Common questions in Virginia

What does an out-of-state pharmacy need to ship compounded peptides to Virginia?

Registration as a nonresident pharmacy under section 54.1-3434.1, a pharmacist in charge licensed in Virginia, and a current home-state inspection report showing compliance with USP-NF standards for sterile and non-sterile compounding. The Department of Health Professions license lookup shows registration status. [1] [4]

Is compounded semaglutide or tirzepatide still available in Virginia?

Only in limited, patient specific cases. The FDA shortage allowances ended in 2025, and Virginia pharmacies must also meet the state's compounding statute, section 54.1-3410.2, so a GLP-1 can be compounded only for a documented need the approved product cannot meet. [3] [11]

Does Virginia have its own compounding law?

Yes. Section 54.1-3410.2 governs compounding in Virginia: it limits compounding to patient prescriptions or observed prescribing patterns, requires USP-NF compliance, sets bulk substance sourcing criteria, and regulates compounded products supplied for office administration. Federal 503A limits apply on top of it. [3] [8]

All peptide legal questions for Virginia